Clinical Trial
Published on 04 Jun 2024
Lipid safety of tenofovir alafenamide during 96-week treatment in treatment-naive chronic hepatitis B patients
in Hepatobiliary Diseases

- 1,194 views
Clinical Trial
Published on 04 Jun 2024
in Hepatobiliary Diseases
Case Report
Published on 30 May 2024
in Hepatobiliary Diseases
Original Research
Published on 30 May 2024
in Hepatobiliary Diseases
Original Research
Published on 22 May 2024
in Hepatobiliary Diseases
Original Research
Published on 17 May 2024
in Hepatobiliary Diseases
Mini Review
Published on 17 May 2024
in Hepatobiliary Diseases
Original Research
Published on 15 May 2024
in Hepatobiliary Diseases
Brief Research Report
Published on 10 May 2024
in Hepatobiliary Diseases
Case Report
Published on 09 May 2024
in Hepatobiliary Diseases
Original Research
Published on 29 Apr 2024
in Hepatobiliary Diseases
Systematic Review
Published on 24 Apr 2024
in Hepatobiliary Diseases
Case Report
Published on 23 Apr 2024
in Hepatobiliary Diseases
Systematic Review
Published on 23 Apr 2024
in Hepatobiliary Diseases
Systematic Review
Published on 05 Apr 2024
in Hepatobiliary Diseases
Original Research
Published on 04 Apr 2024
in Hepatobiliary Diseases
Systematic Review
Published on 28 Mar 2024
in Hepatobiliary Diseases